SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina ILMN.O, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese goods took effect.
The ban is part of a series of measures China announced in response to the extra U.S. tariffs and comes after Beijing put Illumina on its "unreliable entity" list in February.
China accounts for about 7% of Illumina's sales.
China's commerce ministry said in a statement that Illumina "violated the principle of normal market transactions, suspended normal transactions with Chinese enterprises and took discriminatory measures against Chinese enterprises, seriously harming the interest of Chinese enterprises.
"Taking into account the circumstances of the company's violation of the law and other factors, the working mechanism of the Unreliability List in accordance with the law made a decision to prohibit it from exporting gene sequencers to China," it said.
Gene sequences help determine the sequence of DNA or RNA to study genetic variations associated with diseases and diagnose rare genetic conditions.
Illumina did not immediately reply to a request for comment.
(Reporting by Andrew Silver; Editing by Miyoung Kim and Kim Coghill)
((miyoung.kim@thomsonreuters.com; 65 6870 3026; Reuters Messaging: miyoung.kim.thomsonreuters.com@reuters.net))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。